RYAN FEDERICO-PICCIONI: Open Payments
NPI 1720754922 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 19 payments from 7 companies in 2025. Trend: 2023 $199 · 2024 $273 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $125 |
| Sage Therapeutics, LLC | 4 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Organon LLC | 2 | $36 |
| Exact Sciences Corporation | 1 | $30 |
| Organogenesis Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: Veozah, ZURZUVAE, MYFEMBREE, NEXPLANON, Cologuard Collection Kit, CYGNUS DUAL, Qelbree.
Industry payments across NJ — which companies pay providers there.
